PRICE T ROWE ASSOCIATES INC /MD/

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 80255 BALTIMORE, MD

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$710,524

+$40,547 QoQ

Shares Held

158,954

+30.5% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. TSHA ranks #165 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	3,374,955	$2,464,560,888
2	REGN	Regeneron Pharmaceuticals, Inc.	2,177,527	$1,682,444,460
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,760,122	$785,964,877
4	INSM	INSMED Inc	3,092,807	$505,735,799
5	KYMR	Kymera Therapeutics, Inc.	6,060,847	$504,807,946
6	ALNY	Alnylam Pharmaceuticals, Inc.	1,432,748	$474,053,330
7	ASND	Ascendis Pharma A/S	1,530,345	$350,035,811
8	RVMD	Revolution Medicines, Inc.	3,232,213	$314,332,713

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$710,524	158,954	+30.5%	Shares	Defined	2026-05-15
2025-12-31	$669,977	121,814	+7.0%	Shares	Defined	2026-02-17
2025-09-30	$372,240	113,835	+34.6%	Shares	Defined	2025-11-14
2025-06-30	$195,432	84,603	+14.3%	Shares	Defined	2025-08-14
2025-03-31	$102,894	74,025	+13.3%	Shares	Defined	2025-05-14
2024-12-31	$113,022	65,331	+9.4%	Shares	Defined	2025-02-14
2024-09-30	$120,035	59,719	-95.3%	Shares	Defined	2024-11-14
2024-06-30	$2,859,533	1,276,578	+16.1%	Shares	Defined	2024-08-14
2024-03-31	$3,155,074	1,099,329	-10.4%	Shares	Sole	2024-05-15
2023-12-31	$2,172,379	1,227,333	-1.6%	Shares	Sole	2024-02-16
2023-09-30	$3,942,008	1,247,471	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.